These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34619837)

  • 21. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives.
    Mouliou DS; Gourgoulianis KI
    Expert Rev Respir Med; 2021 Aug; 15(8):993-1002. PubMed ID: 33896332
    [No Abstract]   [Full Text] [Related]  

  • 22. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Interrelationship between HIV Infection and COVID-19: A Review of the Literature.
    Wang Y; Lai Y
    Curr HIV Res; 2024; 22(1):6-15. PubMed ID: 38151836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sars-Cov-2 virus and vaccination; biological and statistical framework.
    Arslan F; Ankaralı H
    Expert Rev Vaccines; 2021 Sep; 20(9):1059-1063. PubMed ID: 34365880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Zhang C; Zhou C; Shi L; Liu G
    Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic methods in the COVID-19 pandemic, today and in the future.
    Wu SY; Yau HS; Yu MY; Tsang HF; Chan LWC; Cho WCS; Shing Yu AC; Yuen Yim AK; Li MJW; Wong YKE; Pei XM; Cesar Wong SC
    Expert Rev Mol Diagn; 2020 Sep; 20(9):985-993. PubMed ID: 32845192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.
    Fraley E; LeMaster C; Geanes E; Banerjee D; Khanal S; Grundberg E; Selvarangan R; Bradley T
    BMC Med; 2021 Jul; 19(1):169. PubMed ID: 34304742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronaviruses - a new old menace.
    Golke A; Piekarska K; Dzieciątkowski T
    Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
    Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles and new perspectives in the vaccination against SARS-CoV-2 virus.
    Smetanová J; Střížová Z; Bartůňková J; Milota T
    Cas Lek Cesk; 2020; 159(7-8):298-302. PubMed ID: 33445936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
    Heidler F; Baldt J; Frahm N; Langhorst SE; Mashhadiakbar P; Streckenbach B; Zettl UK; Richter J
    Eur Neurol; 2022; 85(2):104-111. PubMed ID: 34743082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic.
    Palacios R; Mathias A
    Colomb Med (Cali); 2020 Jun; 51(2):e4276. PubMed ID: 33012888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021.
    Williams C; Al-Bargash D; Macalintal C; Stuart R; Seth A; Latham J; Gitterman L; Fedsin S; Godoy M; Kozak R; Guthrie JL; Wood H; McGeer A; Hota S; Rea E
    Clin Infect Dis; 2022 Mar; 74(6):1085-1088. PubMed ID: 34240103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.